ClinicalTrials.Veeva

Menu

CorPath GRX STEMI Study (TREAT GRX)

C

Corindus

Status

Terminated

Conditions

CAD
STEMI - ST Elevation Myocardial Infarction

Treatments

Device: Robotic-PCI (CorPath GRX System)

Study type

Observational

Funder types

Industry

Identifiers

NCT04459299
104-09062

Details and patient eligibility

About

This study will evaluate the performance of the CorPath GRX System in Robotic Primary PCI (RPPCI) in the treatment of ST-elevated myocardial infarction (STEMI).

Full description

This is a prospective, post-market, single-arm, multi-center, observational study to evaluate the performance of the CorPath GRX System during robotic-PCI for acute ST elevation myocardial infarction (STEMI).

Enrollment

3 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥18 and ≤ 80 years
  • Patients with STEMI<12 h of symptom onset
  • Patient deemed appropriate for robotic-assisted PCI
  • The subject has been informed of the nature of the study, agrees to its provisions, and has provided written consent

Exclusion criteria

Cardiogenic shock

  • Cardiac arrest
  • Need for manual or mechanical thrombectomy
  • Failure/inability/unwillingness to provide informed consent
  • The Investigator determines that the subject or the coronary anatomy is not suitable for robotic-assisted primary PCI treatment

Trial design

3 participants in 1 patient group

STEMI patients with clinical indication for primary PCI
Description:
Subjects with a clinical indication of STEMI.
Treatment:
Device: Robotic-PCI (CorPath GRX System)

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

John Van Vleet, MS; Tina Ridgeway, BS, RN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems